Serehale 50/100, 50/250 & 50/500 100 mcg, 250 mcg, 500 mcg Accuhaler
PDF Leaflet Revision Date: 30 March 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylactic treatment of asthma and COPD.
Dosage (summary)
One inhalation twice daily for adults and children 12 years and older.
Onset of Action / Duration
Onset: 30 mins, Duration: 12 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety not established; use with caution.
Key Drug Interactions
- u03b2 adrenergic blockers
- CYP3A4 inhibitors
Contraindications
- Hypersensitivity to fluticasone or salmeterol
Common side effects
- Candidiasis
- Headache
- Tachycardia
Counselling Points
- Use regularly for best effect
- Have rescue inhaler available
Serious warnings
- Not for acute symptom relief
- Potential adrenal suppression
Important Disclaimer
The Serehale 50/100, 50/250 & 50/500 100 mcg, 250 mcg, 500 mcg Accuhaler professional information leaflet below is the property of Innovata Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
